The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of modified gemcitabine/nab-paclitaxel schedules in first line therapy for advanced pancreatic cancer: MI-OPTS-2 study.
 
Camila Carvalho
No Relationships to Disclose
 
Nicole Peterson
Employment - Michigan Medicine
 
Rachel McDevitt
No Relationships to Disclose
 
Kent Griffith
No Relationships to Disclose
 
Allison Schepers
Employment - University of Michigan Health System
Research Funding - Michigan Oncology Quality Consortium (Inst)
Travel, Accommodations, Expenses - Pharmacy Times Continuing Education
 
Ashton Strother
No Relationships to Disclose
 
Grayson Buning
No Relationships to Disclose
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Civala; Civala; Delcath Systems; Elevar Therapeutics; Histosonics; Incyte; Ipsen; Jazz Pharmaceuticals; Lynx Group; Revolution Medicines; SERVIER; Tallac Therapeutics; TransThera Biosciences
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Elicio Therapeutics (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Other Relationship - Rafael Pharmaceuticals (Inst)
 
Arathi Mohan
Stock and Other Ownership Interests - EI Dupont; Johnson and Johnson; Pfizer; Viatris
Research Funding - Verastem (Inst)
Travel, Accommodations, Expenses - DAVA Oncology